Herlev Hospital is a hospital in Herlev, Denmark, close to Copenhagen. The building is 120 metres tall and has 25 floors. It is famous for being Denmark's tallest building. Its modern, functional architecture in bright concrete, glass and bronze-colored aluminum gives a unique impression.

During the past decade, Herlev Hospital conducted 225 clinical trials. In the 10-year time frame, 225 clinical trials started and 54 clinical trials were completed, i.e. on average, 24% percent of trials that started reached the finish line to date. In the past 5 years, 108 clinical trials started and 39 clinical trials were completed. i.e. 36.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herlev Hospital" #1 sponsor was "Herlev Hospital" with 68 trials, followed by "Copenhagen University Hospital at Herlev" with 23 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 15 trials sponsored, "Rigshospitalet, Denmark" with 15 trials sponsored and "Boehringer Ingelheim" with 15 trials sponsored. Other sponsors include 238 different institutions and companies that sponsored additional 143 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herlev Hospital" #1 collaborator was "Rigshospitalet, Denmark" with 30 trials as a collaborator, "Odense University Hospital" with 28 trials as a collaborator, "Herlev Hospital" with 23 trials as a collaborator, "Aarhus University Hospital" with 21 trials as a collaborator and "University of Copenhagen" with 13 trials as a collaborator. Other collaborators include 359 different institutions and companies that were collaborators in the rest 220 trials.

According to Clinical.Site data, the most researched conditions in "Herlev Hospital" are "Prostate Cancer" (11 trials), "Multiple Myeloma" (8 trials), "Ulcerative Colitis" (8 trials), "Colorectal Cancer" (7 trials) and "Breast Cancer" (6 trials). Many other conditions were trialed in "Herlev Hospital" in a lesser frequency.

Most popular intervention types in "Herlev Hospital" are "Drug" (191 trials), "Other" (54 trials), "Procedure" (50 trials), "Device" (31 trials) and "Biological" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "Gemcitabine" (6 trials), "Nivolumab" (6 trials), "Pembrolizumab" (5 trials) and "Oxaliplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Herlev Hospital" are 305 trials for "All" genders, 38 trials for "Male" genders and 30 trials for "Female" genders.

Currently, there are 114 active trials in "Herlev Hospital". 1 are not yet recruiting, 79 are recruiting, 31 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 195 completed trials in Herlev Hospital, 3 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Herlev Hospital, 32 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 35 trials, and there were also 94 trials that are defined as “Not Applicable".

Herlev Hospital has several departments that took part in Clinical trials: "Department of Neurology, Herlev-Gentofte Hospital" - 17 trials, "Steno Diabetes Center Copenhagen" - 16 trials, "Department of Hematology, Herlev Hospital" - 14 trials, "Department of Oncology, Copenhagen University hospital, Herlev" - 40 trials, "Department of Gastrointestinal- and Hepatic diseases, Surgical Section," - 4 trials, "Gastroenheden, Herlev Hospital" - 3 trials, "Herlev Amtssygehus, Kardiologisk" - 3 trials, "Herlev Hospital - Cardiology Research Department" - 2 trials, "Herlev Hospital, Onkologisk Afdeling R" - 2 trials, "Department of Nephrology, Herlev Hospital" - 2 trials, "Dep. of Radiology, Herlev Hospital" - 2 trials, "Unit of Reproductive Medicine, Herlev Hospital" - 2 trials